David M Cherba

David M Cherba

UNVERIFIED PROFILE

Are you David M Cherba?   Register this Author

Register author
David M Cherba

David M Cherba

Publications by authors named "David M Cherba"

Are you David M Cherba?   Register this Author

6Publications

197Reads

28Profile Views

Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.

Clin Cancer Res 2016 Feb 2;22(4):923-34. Epub 2015 Oct 2.

Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan. Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-0187DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500174PMC
February 2016

Melanoma patient derived xenografts acquire distinct Vemurafenib resistance mechanisms.

Am J Cancer Res 2015 15;5(4):1507-18. Epub 2015 Mar 15.

Center for Translational Medicine, Van Andel Research Institute Grand Rapids, Michigan, USA ; Current address: Medimmune, One MedImmune Way Gaithersburg, MD, 20878, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473327PMC
June 2015

MEK2 is sufficient but not necessary for proliferation and anchorage-independent growth of SK-MEL-28 melanoma cells.

PLoS One 2011 Feb 18;6(2):e17165. Epub 2011 Feb 18.

Laboratory of Cancer and Developmental Cell Biology, Van Andel Research Institute, Grand Rapids, Michigan, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0017165PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041822PMC
February 2011